1989
DOI: 10.1093/nar/17.20.8390
|View full text |Cite
|
Sign up to set email alerts
|

A simple and efficient non-organic procedure for the isolation of genomic DNA from blood

Abstract: The isolation of genomic DNA from blood typically involves digestion of nuclei with a combination of Proteinase K and SDS followed by deproteinization with organic reagents such as phenol and chloroform. Additional purification steps such as extensive dialysis, precipitation with a saturated solution of NaCl and/or absolute ethanol are then required for enzymatic analysis of the extracted DNA (1). The isolation procedure described here is both simple and rapid, eliminating the necessity for hazardous organic r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
266
0
8

Year Published

1991
1991
2015
2015

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 452 publications
(274 citation statements)
references
References 3 publications
0
266
0
8
Order By: Relevance
“…Genomic DNA was extracted from peripheral blood of affected and unaffected members of family PMKR60 and the patients and their mother of family M105 using standard procedures. 19 …”
Section: Materials and Methods Participantsmentioning
confidence: 99%
“…Genomic DNA was extracted from peripheral blood of affected and unaffected members of family PMKR60 and the patients and their mother of family M105 using standard procedures. 19 …”
Section: Materials and Methods Participantsmentioning
confidence: 99%
“…DNA isolation was carried out by using the standard protocols. 9 Genotyping and copy number variation analysis…”
Section: Patient Materialsmentioning
confidence: 99%
“…DNA extraction and PCR-based genotyping of TNF␣, LT␣, TNFc, and TNFR1 allelic variants Genomic DNA was isolated from whole buffy coats of participants using standard inorganic salt-out procedures 30,31 High resolution polymerase chain reaction with sequence-specific primers (PCR-SSP) was used to define polymorphisms in the TNF␣ promoter at positions −238 and −308, and at LT␣ position 26. 18 Reference samples whose TNF␣ and LT␣ alleles had been established by DNA sequencing and restriction enzyme digestion were used to validate the SSP-based genotyping strategy.…”
Section: Study Subjects Estimations Of Disease Duration and Clinicamentioning
confidence: 99%